by Emily Burke, PhD | Jun 12, 2019 | Front Page Feature
CRISPR’s GENOME DETECTIVES Last week, we reviewed how CRISPR works and its potential to revolutionize genetic therapies. Here we look at how scientists have started using this technology to develop new diagnostics. Media attention has been focusing almost... 
by Emily Burke, PhD | Jun 3, 2019 | Front Page Feature
CRISPR: SNIPPING AWAY AT DISEASE CRISPR genome editing is one of the most exciting developments in biotechnology since its discovery a few years ago. Bacteria use this mechanism to destroy the DNA of invading viruses. Scientists subsequently discovered CRISPR’s... 
by Emily Burke, PhD | May 28, 2019 | Gene Therapy/Genome Editing
New Gene Therapy Drug Explained Novartis’ (Basel, Switzerland) Zolgensma grabbed headlines last week as it garnered the second FDA approval of a gene therapy treatment for an inherited disease. Designed to treat spinal muscular atrophy (SMA), Zolgensa is also set to... 
by Emily Burke, PhD | May 20, 2019 | Genetic Disease
Hope on the horizon for HUNTINGTON’S No question about it, Huntington’s disease (HD) is cruel. In the beginning, sufferers of this fatal neurodegenerative disorder experience involuntary movement and mood disturbance, most often in the form of depression. As the... 
by Emily Burke, PhD | May 15, 2019 | Groundbreaking New Therapies in Development
Viruses to the Rescue? Last week, a paper in Nature Medicine described a British teenager whom doctors pulled back from the brink of death. The young woman had developed a deadly, antibiotic-resistant infection following lung surgery. The treatment? Phage therapy, in... 
